Immune Modulatory Vaccines Reprogram the Tumor Microenvironment
Could immunomodulatory vaccines reshape the future of cancer treatment? Professor Mads Hald Andersen, Director of the National Center for Cancer Immune Therapy at Copenhagen University Hospital Herlev and Professor at the University of Copenhagen, presents a new approach targeting the tumor microenvironment — with the potential to enhance the effect of existing immunotherapies.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
